SlideShare une entreprise Scribd logo

GTPs vs. cGMPs

•Télécharger en tant que PPT, PDF•
•
W
wrtolbert

The document discusses regulations for human cells, tissues, and cellular and tissue-based products (HCT/Ps) established by the U.S. Food and Drug Administration (FDA) under 21 CFR Part 1271. It provides an overview of the key requirements including establishment registration and listing, donor eligibility screening, adherence to current good tissue practice standards, inspection and enforcement, and the tiered regulatory framework for HCT/Ps. It also compares the new regulations to existing cGMP and quality system regulations.

1  sur  52
WR Tolbert & Associates Consultants to the Biopharmaceutical Industry 11483 Cypress Woods Drive San Diego, CA 92131-3535 858-693-8163 wrt@wrtolbert.com / www.wrtolbert.com
Dogs Bark, Cows Moo, Regulators Regulate... Frank Young, M.D. former FDA Commissioner
FDA History ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
FDA’s Purpose ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA “Centers” ,[object Object],[object Object],[object Object]
FDA Inspections ,[object Object],[object Object]
Foreign Regulatory Agencies ,[object Object],[object Object],[object Object],[object Object]
Information Sources ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Information Sources ,[object Object],[object Object],[object Object]
The Primary Requirement / Roadblock ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Tools ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cross Regulation Themes and Concerns ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Existing Regulatory Environment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
How are Cell-Based Products Different? ,[object Object],[object Object],[object Object],[object Object]
FDA Driving Forces & Challenges for Cell Products ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cell and Tissue Characteristics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Regulation of Cellular and Tissue-based Products ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
New FDA Regulation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271
Regulatory Requirements for HCT/P’s
21 CFR Part 1271 Establishment Registration and Listing ,[object Object],[object Object],[object Object]
21 CFR Part 1271 Donor Eligibility ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271 Good Tissue Practices ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271 Inspection and Enforcement ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271 Inspection and Enforcement ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Compliance to cGMPs, QSRs, and Biologics Regulations vs. cGTPs ,[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Inspections ,[object Object],[object Object],[object Object],[object Object],[object Object]
cGMP Sanctions ,[object Object],[object Object],[object Object]
Additional Valuable cGMP Information ,[object Object],[object Object],[object Object],[object Object]
Open vs. Closed Manufacturing Systems ,[object Object],[object Object]
WRT&A
Material and Supply Flow WRT&A
WRT&A
WRT&A

Recommandé

current Good Tissue Practice
current Good Tissue Practice current Good Tissue Practice
current Good Tissue Practice Arete-Zoe, LLC
 
Preparing an IND Application: CMC
Preparing an IND Application: CMCPreparing an IND Application: CMC
Preparing an IND Application: CMCMaRS Discovery District
 
FDA Regulation of Combination Products
FDA Regulation of Combination ProductsFDA Regulation of Combination Products
FDA Regulation of Combination ProductsMichael Swit
 
21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination Products21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination ProductsJasmin NUHIC
 
Module 1: Introduction to FDA and Quality System Regulations
Module 1: Introduction to FDA and Quality System RegulationsModule 1: Introduction to FDA and Quality System Regulations
Module 1: Introduction to FDA and Quality System RegulationsQAConsulting
 
Food drug and cosmetic act 1938
Food drug and cosmetic act 1938Food drug and cosmetic act 1938
Food drug and cosmetic act 1938swati2084
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsMichael Swit
 
GHTF study group 3
GHTF study group 3GHTF study group 3
GHTF study group 3Nirma University
 

Recommandé

current Good Tissue Practice
current Good Tissue Practice current Good Tissue Practice
current Good Tissue Practice Arete-Zoe, LLC
 
Preparing an IND Application: CMC
Preparing an IND Application: CMCPreparing an IND Application: CMC
Preparing an IND Application: CMCMaRS Discovery District
 
FDA Regulation of Combination Products
FDA Regulation of Combination ProductsFDA Regulation of Combination Products
FDA Regulation of Combination ProductsMichael Swit
 
21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination Products21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination ProductsJasmin NUHIC
 
Module 1: Introduction to FDA and Quality System Regulations
Module 1: Introduction to FDA and Quality System RegulationsModule 1: Introduction to FDA and Quality System Regulations
Module 1: Introduction to FDA and Quality System RegulationsQAConsulting
 
Food drug and cosmetic act 1938
Food drug and cosmetic act 1938Food drug and cosmetic act 1938
Food drug and cosmetic act 1938swati2084
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsMichael Swit
 
GHTF study group 3
GHTF study group 3GHTF study group 3
GHTF study group 3Nirma University
 
21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11roshankhetade2
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best PracticesCFTCC
 
21 CFR, Part 210 and 211 current.pptx
21 CFR, Part 210 and 211 current.pptx21 CFR, Part 210 and 211 current.pptx
21 CFR, Part 210 and 211 current.pptxAartiVats5
 
21 cfr part 210 and 211
21 cfr part 210 and 21121 cfr part 210 and 211
21 cfr part 210 and 211Bhanu Chava
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESvasanthi chodavarapu
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 
INSPECTION OF DRUG DISTRIBUTION CHANNELS
INSPECTION OF DRUG DISTRIBUTION CHANNELSINSPECTION OF DRUG DISTRIBUTION CHANNELS
INSPECTION OF DRUG DISTRIBUTION CHANNELSOORATHI SASIVARDHAN
 
NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)Navalika Polishetty
 
China\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessChina\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessMedTech Review, LLC
 
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...European Center for Disease Prevention and Control (ECDC)
 
Australian regulatory guidelines for biologicals
Australian regulatory guidelines for biologicalsAustralian regulatory guidelines for biologicals
Australian regulatory guidelines for biologicalsNational Institute of Biologics
 
Medical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) ProcessMedical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) ProcessMichael Haessly - SSBB, CQE, CRE, CQM, CSQE, CQA
 
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxSanthiNori1
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inJAYA PRAKASH VELUCHURI
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsadeelzia84
 
National Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) CertificationNational Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) CertificationSanthiNori1
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countriesJAYA PRAKASH VELUCHURI
 
Good manufacturing practices (gmp)
Good manufacturing practices (gmp)Good manufacturing practices (gmp)
Good manufacturing practices (gmp)Marcia Rebelo
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fdaFasika Mekete
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Aakashdeep Raval
 
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...wrtolbert
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceArmin Torres
 

Contenu connexe

Tendances

IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best PracticesCFTCC
 
21 CFR, Part 210 and 211 current.pptx
21 CFR, Part 210 and 211 current.pptx21 CFR, Part 210 and 211 current.pptx
21 CFR, Part 210 and 211 current.pptxAartiVats5
 
21 cfr part 210 and 211
21 cfr part 210 and 21121 cfr part 210 and 211
21 cfr part 210 and 211Bhanu Chava
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESvasanthi chodavarapu
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 
INSPECTION OF DRUG DISTRIBUTION CHANNELS
INSPECTION OF DRUG DISTRIBUTION CHANNELSINSPECTION OF DRUG DISTRIBUTION CHANNELS
INSPECTION OF DRUG DISTRIBUTION CHANNELSOORATHI SASIVARDHAN
 
China\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessChina\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessMedTech Review, LLC
 
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxSanthiNori1
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inJAYA PRAKASH VELUCHURI
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsadeelzia84
 
National Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) CertificationNational Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) CertificationSanthiNori1
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countriesJAYA PRAKASH VELUCHURI
 
Good manufacturing practices (gmp)
Good manufacturing practices (gmp)Good manufacturing practices (gmp)
Good manufacturing practices (gmp)Marcia Rebelo
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fdaFasika Mekete
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Aakashdeep Raval
 

Tendances (20)

21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best Practices
 
21 CFR, Part 210 and 211 current.pptx
21 CFR, Part 210 and 211 current.pptx21 CFR, Part 210 and 211 current.pptx
21 CFR, Part 210 and 211 current.pptx
 
21 cfr part 210 and 211
21 cfr part 210 and 21121 cfr part 210 and 211
21 cfr part 210 and 211
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory Practices
 
INSPECTION OF DRUG DISTRIBUTION CHANNELS
INSPECTION OF DRUG DISTRIBUTION CHANNELSINSPECTION OF DRUG DISTRIBUTION CHANNELS
INSPECTION OF DRUG DISTRIBUTION CHANNELS
 
NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)
 
China\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessChina\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory Process
 
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
 
Australian regulatory guidelines for biologicals
Australian regulatory guidelines for biologicalsAustralian regulatory guidelines for biologicals
Australian regulatory guidelines for biologicals
 
Medical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) ProcessMedical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) Process
 
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproducts
 
National Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) CertificationNational Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) Certification
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countries
 
Good manufacturing practices (gmp)
Good manufacturing practices (gmp)Good manufacturing practices (gmp)
Good manufacturing practices (gmp)
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fda
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
 

En vedette

Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...wrtolbert
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceArmin Torres
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environmentArete-Zoe, LLC
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006Patel Parth
 
Quality Assurance Vs Quality Control
Quality Assurance Vs Quality ControlQuality Assurance Vs Quality Control
Quality Assurance Vs Quality ControlYogita patil
 
InstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP™
 

En vedette (9)

Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection Intelligence
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environment
 
Gmp & glp
Gmp & glpGmp & glp
Gmp & glp
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006
 
GMP
GMPGMP
GMP
 
Quality Assurance Vs Quality Control
Quality Assurance Vs Quality ControlQuality Assurance Vs Quality Control
Quality Assurance Vs Quality Control
 
InstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility Areas
 
Pharmaceutical manufacturing plant
Pharmaceutical manufacturing plantPharmaceutical manufacturing plant
Pharmaceutical manufacturing plant
 

Similaire à GTPs vs. cGMPs

Good Manufacturing Practices
Good Manufacturing PracticesGood Manufacturing Practices
Good Manufacturing PracticesJorge Torres
 
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...MedicReS
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in USAnkit Geete
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINESRaj Tiwari
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devicesmarchell
 
Planning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdfPlanning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdfProRelix Research
 
Understanding FDA Regulations
Understanding FDA RegulationsUnderstanding FDA Regulations
Understanding FDA RegulationsBeth Friedland
 
Quality regulation for biological products current and future
Quality regulation for biological products current and futureQuality regulation for biological products current and future
Quality regulation for biological products current and futureNational Institute of Biologics
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketMethodSense, Inc.
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketMethodSense, Inc.
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesMaRS Discovery District
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsArpitha Aarushi
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...Pubrica
 
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate MedicReS
 
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...UBMCanon
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Eric Dollins
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentJonathan Servoss
 

Similaire à GTPs vs. cGMPs (20)

Good Manufacturing Practices
Good Manufacturing PracticesGood Manufacturing Practices
Good Manufacturing Practices
 
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in US
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
 
Planning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdfPlanning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdf
 
Understanding FDA Regulations
Understanding FDA RegulationsUnderstanding FDA Regulations
Understanding FDA Regulations
 
Quality regulation for biological products current and future
Quality regulation for biological products current and futureQuality regulation for biological products current and future
Quality regulation for biological products current and future
 
FDA Regulations
FDA RegulationsFDA Regulations
FDA Regulations
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to Market
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to Market
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
 
Gcp
GcpGcp
Gcp
 
Advamed MDR IVDR update
Advamed MDR IVDR updateAdvamed MDR IVDR update
Advamed MDR IVDR update
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...
 
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
 
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory Environment
 

GTPs vs. cGMPs

  • 1. WR Tolbert & Associates Consultants to the Biopharmaceutical Industry 11483 Cypress Woods Drive San Diego, CA 92131-3535 858-693-8163 wrt@wrtolbert.com / www.wrtolbert.com
  • 2. Dogs Bark, Cows Moo, Regulators Regulate... Frank Young, M.D. former FDA Commissioner
  • 3.
  • 4.  
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. 21 CFR Part 1271
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49. WRT&A
  • 50. Material and Supply Flow WRT&A
  • 51. WRT&A
  • 52. WRT&A